Capricor Therapeutics CAPR Cash ratio
Cash ratio at other companies
Other financials
Where this comes from
Calculated from Capricor Therapeutics’s reported figures.
Based on the most recent quarter.
The official record: Capricor Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Capricor Therapeutics's cash ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Capricor Therapeutics's cash ratio?
- Capricor Therapeutics (CAPR) reported cash ratio of 3.1× in Q1 2026.
- How has Capricor Therapeutics's cash ratio changed year-over-year?
- Capricor Therapeutics's cash ratio increased by 143.1% year-over-year, from 1.3× to 3.1×.
- What is the long-term trend for Capricor Therapeutics's cash ratio?
- Over 5 years (2020 to 2025), Capricor Therapeutics's cash ratio has grown at a -6.1% compound annual growth rate (CAGR), from 11× to 8×.
- What does cash ratio mean?
- Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.